Last reviewed · How we verify
NCT02526901: BIGCS
The Born in Guangzhou Cohort Study (BIGCS)
trial testing No intervention in Intrauterine Hyperglycemia in 30,000 participants. Currently enrolling.
31 December 2025
Quick facts
| Lead sponsor | Guangzhou Women and Children's Medical Center |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 30,000 |
| Start date | 1 February 2012 |
| Primary completion | 31 December 2025 |
| Estimated completion | 31 December 2030 |
| Sites | 1 location across China |
Drugs / interventions tested
- No intervention
Conditions studied
- Intrauterine Hyperglycemia — all drugs for Intrauterine Hyperglycemia →
- Pregnancy Outcomes — all drugs for Pregnancy Outcomes →
- Neurodevelopment — all drugs for Neurodevelopment →
- Immune Development — all drugs for Immune Development →
Sponsor
Guangzhou Women and Children's Medical Center
Who can join
Eligibility, any sex, with Intrauterine Hyperglycemia or Pregnancy Outcomes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Born in Guangzhou Cohort Study (BIGCS) was established to investigate the short- and long-term effects of exposure in early life on health consequences in Guangzhou, China. Data are collected regarding environmental, occupational and lifestyle exposures as well as health outcomes in later life. Biological samples including blood and tissue samples are also collected from the participants.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Prevalence and Characteristics of Social Withdrawal Tendency Among 3-24 Months in China: A Pilot Study.
Zhou F, Huang P, Wei X, Guo Y, et al · · 2021 · cited 7× · PMID 34220558 · DOI 10.3389/fpsyt.2021.537411
Verify or expand the search:
- PubMed search for NCT02526901
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No intervention
Trials testing the same drug.
- NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
- NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
- NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
- NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
- NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting
Other recruiting trials for Intrauterine Hyperglycemia
Currently open trials in the same condition.
- NCT05794152 — Wenzhou Gestational Diabetes Cohort · NA · recruiting
- NCT04060056 — Westlake Precision Birth Cohort · NA · active not recruiting
Other Guangzhou Women and Children's Medical Center trials
Trials by the same sponsor.
- NCT07190001 — YOLT-204 in Patients With Hemoglobinopathies · EARLY_PHASE1 · not yet recruiting
- NCT06904729 — Chimeric Antigen Receptors T Cells for Refractory/Recurrent Lupus Nephritis in Children · Phase 3 · recruiting
- NCT06948994 — A Clinical Trial on Autologous NK Cells Combined With GD2 Monoclonal Antibody in the Treatment of Children With Newly Di · Phase 1, PHASE2 · not yet recruiting
- NCT06856759 — Single-Dose AAV-MECP2 Safety/Tolerability and Efficacy in Rett Syndrome · EARLY_PHASE1 · recruiting
- NCT06731205 — Long-term Renal Prognosis of Neonatal Acute Kidney Injury · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02526901 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guangzhou Women and Children's Medical Center
- Last refreshed: 26 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02526901.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing